Phreesia, Inc. (PHR)
Chart Events
Performance Outlook
| Previous Close | 25.95 |
| Open | 25.40 |
| Bid | 24.91 x 900 |
| Ask | 24.95 x 3000 |
| Day's Range | 24.50 - 25.56 |
| 52 Week Range | 13.19 - 76.10 |
| Volume | |
| Avg. Volume | 452,773 |
| Market Cap | 1.312B |
| Beta (5Y Monthly) | 0.71 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.08 |
| Earnings Date | Dec 06, 2022 - Dec 12, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 32.92 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for PHR
Related Research
- Phreesia, Inc.Daily – Vickers Top Buyers & Sellers for 09/09/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat28 days agoArgus Research
- Zacks
Can Phreesia (PHR) Climb 26% to Reach the Level Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 25.7% in Phreesia (PHR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- Business Wire
Phreesia Names Alexandra Beneville Vice President of Life Sciences Content Strategy
WILMINGTON, Del., September 22, 2022--Phreesia, a leader in patient intake, outreach and activation, has named Alexandra Beneville as Vice President of Life Sciences Content Strategy. Beneville officially joined Phreesia on Aug. 1, 2022, from Phosphorus, a direct-to-consumer genomic testing company, where she had served as Vice President of Marketing since December 2021.
- Business Wire
Phreesia’s Zeeshan Butt Named to NQF’s MAP Clinician Workgroup
WILMINGTON, Del., September 16, 2022--Phreesia is proud to announce that Zeeshan Butt, PhD, a Director of Clinical Content, has been selected to serve a three-year term as a member of the National Quality Forum (NQF)’s Measure Applications Partnership (MAP) 2022-2023 Clinician Workgroup.
